Hepatic steatosis can stimulate Kupffer cells to release inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), thus creating a vicious cycle that exacerbates both IR and dyslipidemia (34). Here, IL6 is linked to metabolic syndrome.